Kailera Therapeutics, Inc. (KLRA) stock
Close on Nov 12, 2026Market cap $1.71BP/E –Yield –
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Sep 30, 2026
Valuation
- Market cap
- $1.71B
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 1.66
- Dividend yield
- –
- Free cash flow yield
- –
Fundamentals
- Book value per share
- $7.95
- Diluted shares
- 130M
Trading
- Previous close
- $14.38
- Open
- $14.31
- Day's range
- $13.19 – $14.31
- Volume
- 563,118
- Average volume (20 days)
- 966,538
- Index membership
- Russell 2000 (since Jun 2026), Russell 3000 (since May 2026)
- RSI (14 days)
- 52.2
- Volatility (1 year)
- 73.0%
- Relative volume
- 0.62×
On 1 of our idea list: More cash than they're worth
Index membership is inferred from the holdings of funds that track each index (IWM, IWV), as reported to the SEC for Jun 30, 2026. Join dates come from quarterly fund reports since 2019, so they are accurate to the quarter.
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.
| Period | KLRA | S&P 500 | Difference | KLRA per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +16.6% | -2.7% | +19.3 pts | ||
| 3 months | -28.9% | -1.7% | −27.2 pts |
Two years at a glance
Fiscal years 2024 to 2025, USD
Press releases
Releases Kailera Therapeutics filed with the SEC as exhibits to Form 8-K or 6-K
Kailera Therapeutics stock: common questions
What is Kailera Therapeutics's stock price?
KLRA closed at $13.21 on Nov 12, 2026, down 8.14% on the day.
What is Kailera Therapeutics's market cap?
Kailera Therapeutics was worth $1.71B at the close on Nov 12, 2026: the share price times the diluted shares outstanding.
Does Kailera Therapeutics pay a dividend?
No. Kailera Therapeutics has not paid a cash dividend over the last twelve months.
How many KLRA shares are sold short?
8M shares were sold short at the latest FINRA report, 15.59% of the float, or 7.8 days of average trading volume.
Who are Kailera Therapeutics's competitors?
Companies most similar to Kailera Therapeutics by business, industry and size include LLY, JNJ, ABBV, MRK, AZN.
See a number that looks wrong?